FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE ...

Ultrahuman has launched M2 Live in the US, combining Abbott's Lingo glucose monitor with AI-powered metabolic insights at a ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has cleared the first over-the-counter monitor that continuously checks glucose levels. The ...

This popular CGM can now be marketed for children 2 years of age and older who do not use insulin.

Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...

Federal regulators have authorized the first over-the-counter continuous glucose monitor (CGM) for children. Officials at the ...

More than 500 million people worldwide live with diabetes, making reliable continuous glucose monitoring (CGM) a critical yet ...

Rutherford, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization ...

Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering research. An interdisciplinary research team, including the Faculty of ...

For many years now, it has been rumored that the Apple Watch will eventually gain non-invasive blood sugar monitoring capabilities, which would enable millions of people with diabetes to track their ...

According to MarketsandMarkets™, the Patient Monitoring Devices Market is projected to grow from about USD 55.60 billion in 2026 to USD 76.11 billion by 2031, at a CAGR of 6.4%.

Authorization of Stelo integrated CGM extends to children without diabetes as well ...